Hak-Cheol Kwon

Title: Hak-Cheol Kwon: Neurodegenerative Disease Research and Patents.

Introduction

Hak-Cheol Kwon is an inventor associated with Seoul, South Korea, and the Korea Institute of Science and Technology. His patent work focuses on potential approaches to preventing or treating neurodegenerative diseases. His portfolio includes 2 patents.

Latest Patents

One patent disclosure describes using an extract, or compounds isolated from it, to inhibit beta-amyloid production and potentially prevent or treat neurodegenerative disease. The disclosed active ingredients include dihydrolycoricidine, 2-methoxypancracine, lycoricidine, and lycoricidinol. The disclosure also covers related compositions, methods of use, and preparation methods.

Another disclosure concerns compositions containing longan arillus extract, alone or in a combined extract, for preventing or treating neurodegenerative disease. It describes protective effects on dopaminergic neurons against MPTP-related neurotoxicity and toxicity associated with alpha-synuclein protein aggregation.

Career Highlights

Kwon’s listed patent disclosures connect natural-product extracts and their compounds with research into neurodegenerative disease. The work explores both beta-amyloid production inhibition and protection of dopaminergic neurons.

Collaborations

Kwon’s listed coworkers include Hyun-Ok Yang and Sung-Kwon Chung. The patent disclosures identify research associated with the Korea Institute of Science and Technology.

Conclusion

Hak-Cheol Kwon’s patent portfolio reflects research into natural-product-based approaches to neurodegenerative disease, including beta-amyloid inhibition and dopaminergic neuron protection.